Delivery Order SPE2DB20D9135-SPE2DB24FZW71
Award Date
3/11/24
Potential Completion Date
4/1/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,308.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, with a period of performance through May 13, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999, which allows the DLA to issue delivery orders for a...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,759.56, is for the supply of ACTEMRA 400 MG/20 ML VIAL 20ML. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,923.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with an ultimate completion date of April 25, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, valued at up to $4,999,999 and held by DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $4,385.04 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of 4564299269 - Actemra Actpen 162 mg/0.9 ml 0.9ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB24FYW67) between DMS Pharmaceutical Group and DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,846.72, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a biologic medication. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award for $1,461.70 was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The award is a delivery order under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract with DLA for a broad range of pharmaceutical products, including prescription drugs, biologics, and medical supplies to support the recurring needs of military health facilities globally. The contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The firm-fixed-price delivery order, valued at $10,231.76, has an ultimate completion date of May 9, 2024. This award is part of a larger indefinite-delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which allows the DLA to issue delivery orders...
The U.S. Defense Logistics Agency has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Actemra Actpen 162 mg/0.9 ml medication. The contract, valued at $6,577.56, has a completion date of February 21, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois and holds a larger indefinite delivery contract with DLA valued up to $4,999,999 through 2025 for a broad range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract has a ceiling value of $13,155.12 and an ultimate completion date of August 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, which has a potential value of up to $499,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, with a completion date of February 20, 2024 and a firm fixed price of $2,923.36. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a wide range of...